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Abstract 
 
Particulate solids attract a lot of industrial interest as they are used so widely, particularly 
in the agro-food, pharmaceutical, cosmetics and mineral industries. However they are also the 
focus of a lot of scientific attention while their generation, their formulation and the control of 
their usage properties are still not well understood and mastered. In the domain of particle 
formation, processes using crystallisation from a supercritical medium constitute a new route to 
obtain finely divided solids. By using pressure as an operating parameter, these processes lead to 
the production of fine and monodisperse powders.  
Previously to the study of the processes, it is necessary to know the solubility of the 
studied solids in supercritical phases which require the knowledge of the behaviour of the 
different fluid and solid phases involved. 
There exist two families of processes, according to whether supercritical fluid - usually 
carbon dioxide - is used as a solvent or an anti-solvent: RESS or SAS. In the first case it is the 
drop in density due to the sudden decompression of the fluid, which is the driving force of 
nucleation. Because of its simplicity, RESS remains the first process to be tested and a large 
amount of different materials have been processed through RESS and its derivatives. Its main 
limitation lies in the rather poor solubility of several families of molecules in carbon dioxide. 
In the SAS process, it is the reciprocal dissolution of an organic solvent in the supercritical fluid 
which leads to the particle precipitation. The universality of SAS (there is always a proper 
solvent-antisolvent couple for the studied solute) will ensure future developments for very 
different type of materials. Very often, semi-continuous SAS process and RESS process can 
compete for pre-industrial particle generation 
Supercritical-assisted particle formation has made a lot of progress in the recent years. 
Both RESS and SAS processes continue to undergo fundamental and applied research and have 
benefited from the recent years’ advances. Even if several controversial issues are still in debate 
in the scientific community, industrial applications are expected soon in many sectors, though it 
is the pharmaceutical industry which seems best equipped to gather a majority of its 
developments. 
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I. INTRODUCTION 
I.1. Phase diagram of pure components 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure1: state surfaces of a pure component (courtesy of P. Carles) 
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The well-known phase diagram is probably the best way to introduce supercritical fluids and their 
properties.  
A pure component can be characterised by two and only two of variables-of-state. If, for 
instance, P and T are fixed, then the density (or the molar volume V) can only take one value. 
Another way to express this fact, is to say that these three variables are linked by an equation 
of state (EoS): f (P, V, T ) = 0 
 
 This is shown on figure 1 where the so-called state surfaces are represented on a three-
dimensional diagram. On the more classical P,T  or P,V diagrams, special projections of the first 
diagram, the phase change lines: sublimation, fusion and vaporisation are evidenced as well as 
two remarkable points.  
On the P, T diagram, the triple point is the point where the solid, liquid and gaseous state 
coexist and the critical point ends the vaporisation curve under which liquid and vapour coexist. 
 On the P, V diagram, there is a triple line where the three states coexist, while the critical 
point is the maximum of the vaporisation curve. 
 
I.2. The supercritical state 
 
Beyond the critical point i.e. P > Pc and T > Tc, a pure compound is no longer either liquid or 
gaseous. It is in a state called "supercritical". In other words, at T > Tc, a gas cannot be liquefied 
by increasing the pressure. It is noticeable however, that by turning round the critical point (see 
arrows on figure 1) it is possible to go from the gaseous state to the liquid state (or vice-versa) 
without being subject at any time to a phase change. 
 
Historically, it was the French researcher Cagniard de la Tour who first described this third 
state of matter in 1822 [1]. He performed experiments with a flint stone bead and alcohol 
introduced in a sealed barrel of a rifle. He noticed that at high pressure and temperature, the 
sound of the bead in the barrel had changed and it seemed as if the liquid had vanished. This was 
the first description of this peculiar state known today as the supercritical state. 
 
The supercritical state exhibits properties, which are generally intermediate between those of 
liquids and gas. However some are much closer to those of liquids, this is the case of density 
while other properties such as viscosity are much more gas-like (see table 1). 
 
 
 
 
 
 
 
  
Table 1 . Comparison of the properties of liquids, gases and supercritical fluids 
 
 Density 
(kg. m-3) 
Viscosity 
(Pa.s) 
Mass auto-diffusion 
coefficient 
(cm2.s-1) 
Gas 0.6 to 2 1 to 3 10-5 0.1 to 0.4 
SFC at Tc, Pc 200 to 500 1 to 3 10-5 0.7 10-3 
SFC at Tc, 4Pc 400 to 900 3 to 9 10-5 0.2 10-3 
Liquid 600 to 1600 0.2 to 3 10-3 0.2 to 2 10-5 
 
 
From this table it can be deduced that SCF are good solvents since solvent power is 
proportional to density. Their density is close to that of liquids but conversely to liquids a SCF is 
compressible, which can be of great interest. 
 
 
 
 
 
A first consequence of this compressibility is shown on figure 2. This figure shows typical 
isobar curves of solubility in a supercritical solvent.  
Another fundamental property of the SFC can be deduced from this curve: by varying the 
operating pressure, the concentration of a solute can dramatically change. Therefore SCF 
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TC
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T
Figure 2 . Solubility in a supercritical solvent
  
are tuneable solvents which explains the numerous industrial applications of extraction using 
these solvents. 
 
On figure 3, the reduced density rr (the ratio of the density divided by the density at the 
critical point) has been plotted versus the reduced pressure Pr.  
This figure shows another aspect of this peculiar solvent power: that of staying in a zone 
where the density is at the same time close to that of a liquid (rr > 1) and very sensitive to 
pressure variation, it is necessary to work not too far from the critical point. In other words, the 
reduced temperature must be in the interval 1 < Tr < ~1.2 and the reduced pressure must be less 
than 4 to 5.  
However, in the very close vicinity of the critical point, there is an infinite compressibility as 
expressed by the vertical slope of the curves. At this point the thermal diffusivity tends towards 0. 
In consequence, to avoid strong thermo-mechanical instabilities it is advisable to perform 
experimental work outside this zone. 
 
 
Therefore, a supercritical fluid can be considered as a good solvent with large adjustable 
solvent power. Moreover the transport properties (high mass diffusion coefficient) and the low 
viscosity imply that the SCF will be able to penetrate into porous matrices like a gas or at least 
much more easily than a liquid. 
 
 
 
1
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Figure 3. Variation of the density in the critical zone
  
In summary, a SCF can be described as a dense but compressible fluid with good mass 
transfer properties. Moreover, these properties are easily tuneable by simple variations of  
temperature or more often pressure. 
It is the combination of these properties, which explain the development of SCFs as extraction 
solvents since the seventies. 
 
A great number of chemicals have been investigated as potential industrial supercritical 
solvents. Ethylene [2], ethane[3], nitrous oxide [4], and carbon dioxide were among the most 
used. Xenon [5], methanol [6], and other light hydrocarbons[7], have also been tested. 
Supercritical water has also been studied [8], however its critical co-ordinates are rather difficult 
to reach (Tc = 647 K) and industrial applications are still limited to toxic wastes oxidation [9].  
Table 2 shows Tc, Pc and rc for some usual chemicals.  
 
 
 
Table 2. Critical co-ordinates of some usual chemicals 
 
 Tc (K) Pc (Mpa) rc (kg/m3) 
CO2 304.1 7.38 468 
N2O 309.5 7.24 457 
CH4 190.6 4.59 163 
H2O 647.1 22.1 322 
NH3 405.4 11.3 235 
Ethanol 516.1 6.3 276 
Ethane 305.3 4.88 203 
Ethylene 282.3 5.04 215 
n-propane 369.8 4.25 217 
 
 
 
This table explains the choice of CO2, which is the far most widely used supercritical fluid. Its 
Pc and Tc are relatively easy to reach.  
In addition, its solvent power is relatively close to those of chlorinated solvents (CHCl3, 
CH2Cl2, CFC’s) and normal alkanes like hexane which are already or might soon be banned. 
Nevertheless, CO2 is a poor solvent for polar molecules [10]. However, Beckman [11] showed 
that CO2 can also solubilise highly polar compounds provided adequate CO2-soluble surfactants 
(like fluoro-ethers) are used.  
Another property has recently been described by Fages et al. [13, 14]: SC-CO2 can inactivate 
human viruses in bone tissue and can hence be used to process bone allografts in bone banks. 
Finally, it exhibits several other advantages: it is natural, cheap, easily available, gaseous at 
atmospheric pressure, non toxic and non corrosive. It is recycled from the fertiliser industry (it 
  
comes from the environment and will return to it after use) and therefore, in this way, does not 
add to the greenhouse effect.  
 
However, there is another property of the SCF's which has been recently under the spotlights: 
the ability to generate fine solid particles from supercritical solutions. 
The first report was made by Hannay and Hogarth in 1879 [14] who reported the formation of 
"snow" and “frost” in a gas submitted to cycles of compression-decompression. Today this report 
is considered as the first RESS process (see chapter 4) ever performed. 
This property was re-discovered in the early eighties and Krukonis made a report at the 1984 
annual meeting of the AIChE [15], which can be considered as the first paper in his area. This 
property will be described later in this paper. 
 
 
  
II. SOLID SOLUBILITIES AND PHASE EQUILIBRIA 
 
The comprehension of the phase equilibria between a heavy solid and a light supercritical 
solvent is necessary to develop a scientific approach of the particle generation processes [16, 17, 
18]. This chapter gives some of the basic information required. Most of the chapter will be 
devoted to binary systems but the ternary systems will also be evoked at the end. 
II.1. Modelling the solubility of a solid in a SCF 
 
The solubility of a solid (expressed as a mole fraction) in an ideal gas is the ratio of the 
sublimation pressure (which depends only on temperature) over the total pressure of the system:  
 
/ P 
 
A supercritical fluid does not behave as an ideal gas since the theory of ideal gases implies 
that the molecules of the gas do not interact. On the contrary a supercritical fluid is dense which 
explains that -fortunately- the solubility of a given solid is much higher than the theoretical 
solubility in an ideal gas. 
 
The ratio of these two solubilities has been called the enhancement factor E. In the following 
equation y2 is the mole fraction of the solute in the fluid. 
 
 
Eq. (1) 
The mole fraction of a solute is given by the following equation in which the subscript 2 refers 
to the solute. V2s is the molar volume of the pure solid, while j2 is the fugacity coefficient in the 
fluid phase, traducing the deviation to ideality of the fugacity noted f. 
 
f2= P y2 in an ideal gas and f2 = j2 P y2 in a real fluid. 
The enhancement factor can be as high as 106 . 
 
 
 
Eq. (2) 
 
The molar volume in the solid phase is assumed to be constant over a very broad pressure 
range and can be estimated easily by experiment.  
 
 
E = P y2P2sat
y2 =
P2sat
ϕ2P
exp 
V2
S
RT P − P2
sat( )
⎡ 
⎣ 
⎢ 
⎤ 
⎦ 
⎥ 
P2sat
  
The fugacity coefficient j2 can be calculated by means of an equation of state (see & 2.2). 
Then, the mole fraction of the solute can be calculated provided the sublimation pressure (a 
function of T) is known. In some cases Psat can be estimated [19]. 
However, the solute can be a new or unusual molecule for which no thermodynamic data can 
be found in the literature. Such data can be estimated or experimentally measured -very often 
requiring a hard work- or another strategy can be developed for solubility prediction using 
empirical models based on the correlation between solubility and fluid density. 
 
II.2. Equations of state EoS  
 
For a review of the use of equations of state for the calculation of fluid-phase equilibria, see 
the paper of Wei and Sadus [20]. 
 
Pure components:  
 
As already stated in the introduction an equation of state of a pure component is of the form:  
f (P,T,V) = 0. 
Mariotte's law , known as the ideal gas law is: 
 
PV = RT 
 
However, this law is valid only at low pressures when gases can be considered to be "ideal 
gases". 
To take into account the interaction between the molecules several EoS have been proposed. 
Van der Waals equation introduces two parameters, a and b.  
• a represents an attractive effect between the fluid molecules (e.g. as shown by tension surface 
forces) . 
• b is known as the co-volume, it is the lower limit of the molar volume when the most compact 
arrangement of the molecules can be achieved. 
 
    
 
 
Eq. (3) 
 
 
This equation is said to be "cubic" since the molar volume can be calculated from the pressure 
by a polynomial equation of degree 3. 
a and be can be calculated by using the infinite compressibility at the critical point:  
 
P = RTV − b −
a
V 2   
  
 
 
Eq. (4) 
 
The values are:  
 
 
 
Eq. (5) (6) 
 
This equation allows calculating of the critical values for P,T and V and by replacing these 
variables by their reduced values:  
 
 
Eq. (7) 
 
This universal equation known as the "corresponding state law" expresses the fact that all the 
pure components which follow the VdW equation share the same behaviour. 
Several other analytical EoS have been proposed in order to improve the VdW equation. The 
most used are the Peng-Robinson EoS  [21]: 
 
 
Eq. (8)  
 
and the modified Redlich - Kwong - EoS proposed by Soave in 1972 [22]: 
 
 Eq. (9) 
 
These equations were proposed to improve the pertinence of the term a in the VdW equation. 
There are of great help and exhibit good accuracy provided the calculations are not made in close 
vicinity to the critical point [23]. 
 
 
Binary mixtures:  
 
For a binary mixture, EoS can be used with the mole fraction yi of each component (y1 + y2 = 
1).  
 
∂P
∂V
⎛ 
⎝ 
⎞ 
⎠ Tc
= 0     et     ∂
2P
∂V 2
⎛ 
⎝ 
⎜ ⎞ 
⎠ Tc
= 0
a = 2764
R2Tc2
Pc
    and  b = 18
RTc
Pc
Pr =
8Tr
3vr −1
−
3
vr 2 
 
P = RTV − b −
a(T)
V 2 + 2bV − b2 
P = RTV − b −
a(T)
V 2 + bV 
  
The EoS is of the form:  f (P,T,V,yi) = 0 
 
In the VdW equation, a and b are a function of yi and of the ai and bi coefficients for each pure 
component of the mixture: 
 
 Eq. (10) 
 Eq. (11) 
 
a12 and b12 are given by the following expressions:  
 
 Eq. (12) 
 Eq. (13) 
 
 
The equations giving a12,b12 and kij (the binary interaction parameter ; 0< kij < 1) are known as 
the "VdW mixing rules" or the "classical mixing rules" .  
These mixing rules can be generalised to any EoS parameter l of a mixture with n 
components:  
 
 Eq. (14) 
 
Several authors have proposed more sophisticated mixing rules for better solubility prediction 
especially when specific interaction (hydrogen bonds) are found. 
With these rules one can calculate the fugacity coefficient and therefore the mole fraction of 
the solute. 
 
 
II.3. Density-based models 
 
Another approach for modelling solid solubilities in SCF's is to correlate the solubility to the 
fluid density. Several authors have noticed that the logarithm of the solubility is a linear function 
a = a1y12 + 2y1y2a12 + a2y22
b = b1y12 + 2y1y2b12 + b2y22
a12 = (1 − k12) a1a2
b12 =
1
2 (b1 + b2 )
λmix =
j
n
∑ λij
i
n
∑ yiyj
  
of the density or sometimes of the logarithm of the density. Kumar and Johnston [24] have shown 
that this type of correlation is valid in a domain 0.5 < rr < 2.0. 
This type of correlation is very useful since there are relatively easy to apply without the 
knowledge of thermodynamic data very often lacking for new molecules. 
 
The Chrastil model [25] is probably one of the most used. In this model k molecules of the SCF 
form a complex with one molecule of the solute:  
 
 
Eq. (15) 
 
C2 is the concentration  (in g. l-1) of the solute in the fluid, a and b are constants characteristics of 
the mixture solute-fluid. 
This equation can also be written in the form:  
 
 
 
Eq. (16) 
 
r is the density of the fluid which is generally assumed to be the same as that of the pure solvent 
and which can be calculated via an EOS. The number of fluid molecules k involved in the 
complex is not necessarily an integral. k, a and b are adjusted in order to best fit the experimental 
data. 
 
 
The enhancement factor E can also be represented as a function of the density logarithm. 
Mendez-Santiago and Teja [26] have shown that the following equations are valid in the domain 
0.5 < rr < 2.0: 
 
 
 Eq. (17) 
 
The knowledge of E implies that the sublimation pressure at the given T is known. When it is not 
the case, these authors propose another equation in which the sublimation pressure has been 
replaced by an equation in 1/T. This gives an equation with a dependence between the mole 
fraction of the solute and the fluid density and the temperature:  
 
 Eq. (18) 
 
a, a', b, b' and g are independent of T and can be adjusted on experimental data. 
Finally, in another paper, the same authors [27] have improved equation (17) by taking into 
C2 = ρk  exp(
a
T +  b)
ln C2 = k lnρ +
a
T + b
T ln  E =  α +  β ρ
ln  y2 =  α'  +  β'  ρ + γT
  
account the co-solvent mole fraction, y3:  
 
 Eq. (19) 
 
a”, b”and d are three new adjustable parameters. 
Another semi-empirical correlation by Ziger and Eckert [28] gives the logarithm of E as a 
function of thermodynamic properties of both the solvent and the solute. 
Recently, Sauceau et al. [29] have extended and improved these three models. They  propose a 
new equation valid whatever the co-solvent: 
 
 
Eq. (20) 
 
vs. r,  where superscript cos means cosolvent. By plotting                                        
 
the solubility data of naproxen in carbon dioxide (data from literature with 4 different co-
solvents) are gathered on a single line.  
 
Influence of P, T and r on the solubility of a solid in a SCF 
 
Effect of T 
 
The influence of temperature on solubility takes into account two antagonistic phenomena. 
When T increases, the density tends to decrease which corresponds to a lowering of the solvating 
power. However, this rise in temperature gives at the same time an increase in the sublimation 
pressure of the solute, which has an opposite effect on solubility. It has been observed that at 
intermediate pressures (in th 
e zone where the compressibility is very high) it is the first phenomenon, which is 
predominant while the second is predominant at high pressures. Therefore the isotherms of 
solubility exhibit the trends shown in figure 4 with a crossover pressure (there is another 
crossover pressure in the low-pressure zone not represented on this figure, see figure 5.). The 
region in which solubility decreases when the temperature rises is known as the retrograde 
region. With two different solutes having a different crossing point there is a domain where 
increasing the temperature will increase the solubility of one solid and decrease the solubility of 
the other. Chimovitz et al. [30] developed a process for the separation of solid mixtures base on 
this rationale. 
 
 
T ln E( ) = α" +β"ρ f + δy3
T ln E( ) = A + Bρ f + C T + Dcosy3cos
cos
∑
T ln E( ) − CT + Dcosy3cos
cos
∑
  
Figure 4. Influence of temperature on solubility 
 
 
Effect of P  
 
Figure 5. Solid solubility behaviour in SC CO2 vs. pressure 
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Over a very large range of pressure, the fugacity coefficient j2 decreases very rapidly when 
pressure increases, explaining the observed increase of solubility (j2 is at the denominator in the 
equation). At low pressures this may change and a decrease of solubility with increasing pressure 
can be obtained  as shown in figure 5. This is the behaviour of an ideal gas. 
At very high pressures, the solubility becomes almost insensitive to pressure.  
 
Effect of r 
An increase in density leads to an increase in solubility. Intermolecular distances are lower 
and specific interactions between the solvent and the solute are enhanced. The dependence of 
solubility vs. density is explicited in & 2.3. 
 
II.4. Solid-fluid phase diagrams 
 
Two main types of diagrams P, T can be encountered:  
 
In these diagrams, subscript 1 and 2 refer to the fluid and the solid respectively. 
In the simplest case on the left diagram in figure 6, there is a continuous critical curve linking 
the two critical points of each component. A curve of coexistence of three phases (S-L-V) also 
appears. The shape of this curve shows that the melting point of the solid (the temperature at 
which a liquid phase appears) may decrease while the pressure is increasing. This phenomenon is 
known as the melting point depression. It corresponds to a dissolution of the light component into 
the solid leading to an easier fusion. 
 
CP1
TP2
P
S-L-V
T
CP2
CP1
TP2
P
T
CP2
lcep
ucep
S-L-V
S-L-V
S-L2
S-V2
L-V2
Figure 6. The main types of solid-fluid phase diagrams
  
This diagram represents a case where the fluid and the solid are "similar" in terms of 
molecular size and structure. It is seldom the case in industrial applications. 
 
The more common case when there is a very different structure between the fluid (very often 
CO2) and the solid (very often a much bigger molecule with polarity) is represented on the right-
hand side diagram of figure 6. In this figure, the critical curve is no longer continuous. In the 
same way, the SLV curve has also split into two separate curves. 
Two remarkable points appear: the lcep (lower critical end point) and the ucep (upper critical end 
point). Between these two points appears a “temperature window” of solubility in which 
whatever the pressure, there are only coexistence of a solid phase and a vapour phase with some 
heavy component dissolved.  
How to use these diagrams: depending on the T,P operating conditions, several cases from a 
single monophase to a three-phase system can be encountered [31]. It is the P,y2 or T,y2 diagrams 
which can give the exact configuration. 
 
II.5. Ternary systems 
 
In many industrial applications a third component is involved. It may be a co-solvent which is 
able to enhance the solubility of a solute in the SCF. In particle design, the RESS process might 
be concerned. It may also be a solvent of the solute, the solution being then used in a process 
where the SCF is used as an anti-solvent (SAS process). Pöhler & Kiran [32, 33] have 
investigated the volumetric properties of CO2 with a cosolvent. The mixture composition may 
become an additional parameter for an improved control of the process involved.  
 
 
The co-solvent effect:  
 
A co-solvent is a small polar molecule (light alcohol, acetone,..) which is added at low 
concentration in a supercritical fluid to modify its solvent power [34, 35]. The effect on solubility 
of some molecules may be tremendously affected. It is not rare to increase the solubility 100-fold 
with a few molar percent of a co-solvent. 
 
A co-solvent changes the fluid density and its P,V,T properties. In addition, it can creates 
molecular specific interactions with the solute: hydrogen bonds, dipole interactions... Dobbs et al. 
[32, 33] studied the influence of polar and non-polar co-solvents. They showed that a polar co-
solvent which can create hydrogen bonds with a solute increase the solubility in a non-polar 
supercritical solvent like CO2. 
 
 
 Phase diagrams:  
 
 Isothermal ternary diagrams, presented as triangles with one of each component at each corner 
  
are mainly used. To take into account the pressure variation the diagrams can be packed one on 
top on the others as shown on figure 7. 
 
 
In this example the SCF and the solute are insoluble while the SCF is more and more soluble 
in the solvent as the pressure increases. The solvent and the solute are miscible at all pressures. 
The diagrams are represented for a temperature higher than the SCF critical temperature. 
Each side of the prism is in fact a (P,y) diagram. On the side SCF-Solvent the dotted-line 
represents the pressure-composition behaviour of this binary mixture. 
This example is a simple one with only a single-phase zone beyond the binodal curve and a 
two-phase zone under the binodal curve. 
 
More complex diagrams can be encountered. Kikic et al. [38] gave an analysis of three-phase 
equilibria in binary and ternary systems for applications in particle generation processes.  
 
II.6. Solubility measurements 
 
The experimental techniques which can be developed for measuring solid solubilities in a SCF 
can be classified in two major groups [39]: synthetic methods and analytical methods.  
 
P'
Solute SCF
P"
P
 Solvent
Figure 7. Phase diagram for a ternary mixture
P < P' < P" 
 
  
Synthetic methods involve the determination of equilibrium without sampling. They normally 
require a static view cell of which the volume can be varied by any adapted system. It is the 
visual determination of the appearance or disappearance of a phase (bubble, dew) which gives the 
experimental data points. Once loaded with known amounts of the mixture to be studied a 
variation of temperature and cell volume allows the scanning of the P,T diagram. 
 
In analytical methods, the compositions of the phases in equilibrium are obtained by analysis 
after sampling. These methods are the most widely used for determining solid-fluid equilibrium.  
Among them there are the static and the phase-circulation methods. In the static methods, the 
solid is put in contact with the fluid and the mixture is allowed to attain an equilibrium state in 
appropriately stirred conditions. In these methods the difficulty is to get a sample without 
disturbing the equilibrium in order to have a good relevance of the analysis. 
In the phase-circulation methods, a known quantity of fluid is allowed to re-circulate through a 
column in which the solute has been disposed, providing the agitation necessary to achieve 
thermodynamic equilibrium. 
 
Finally, there are dynamic open-flow methods where the fluid passes through a bed of the 
solid. The fluid flow (which determines the contact time), the geometry of the equilibrium cell, 
determine whether or not the residence time is long enough to reach the equilibrium.  
 
 An example of such device is given on the figure 8. This apparatus was designed and built by the 
phase equilibria research team in the Ecole des Mines de Paris at Fontainebleau, France. It is 
based on a dynamic analytical method.  
This apparatus was developed by Sauceau and co-workers to measure solid solubilities in pure 
CO2 and in CO2 plus a co-solvent [40]. Data obtained on naphthalene have been successfully 
compared to those in the literature [2, 41]. A specific study on a pharmaceutical molecule was 
then performed [42, 43].  
 
  
 
 
 
 
 
The equilibrium cell has been designed to achieve efficient stirring and efficient mass transfer 
in order to have the exiting supercritical mixture at thermodynamic equilibrium. A back pressure 
regulator (BPR) allows a constant pressure in the line. At the outlet, where the supercritical fluid 
is expanded to atmospheric pressure, the solid is allowed to crystallise and is immediately 
solubilised by a recovery liquid solvent stream. The apparatus is designed to avoid any dead 
volume and potential clogging by the solid, a problem encountered with most of the open circuit 
techniques used to measure solubilities in supercritical fluid.  
The solubility of the solid in supercritical fluid is calculated from the total volume of gaseous 
solvent (extraction solvent) used and the concentration of solid in the recovery solute liquid 
phase. From these two measurements and knowing the total volume of the recovery solute liquid 
solvent, the solubility of the solid in the supercritical fluid can be calculated. 
hea ter , H, is used to rapidly hea t the solvent to
tempera tures above it s cr it ica l tempera ture. The su-
percr it ica l flu id then enters an oven (Spame), where the
solubility cell is thermoregula ted. The oven can be used
for temperatures up to 400 K, with temperature regula-
t ion with in 0.1 K. Because of the thermal iner t ia of the
equilibr ium cell, it s in terna l tempera ture is found to be
stable to with in 0.05 K. A hea t exchanger , HE, con-
ta ined in the oven , is used to set the tempera ture of the
solvent a t the desired level (temperature of the required
solubility measurement ) before it en ters the solubility
cell. HE consist s of a brass cylinder around which is
wound the sta in less steel solvent circu it . The cylinder
and tubing are covered with a brass radia tor . Down-
st ream of th hea t exchanger , a six-way, two-posit ion
high-pressure Valco va lve is loca ted in the circu it to
either direct the supercr it ica l flu id to the cell or bypass
it . This provides a means for removing eventua l solid
deposit s from the line. Cylindr ica l in shape, the cell EC
contains three compartments placed one above the other
and fit t ed a t their bot toms with sta in less steel sin tered
disks and O rings. This is equiva len t to three differen t
cells connected in ser ies. The solid powder , for which
solubility measurements are required, is placed inside
the three compar tments, which have a tota l volume of
about 5 cm3. The sin tered disks prevent st r ipping of the
solid dur ing the exper iment and a llow a small pressure
drop, advantageous for a t ta in ing sa tura t ion , while a
good dispersion of the supercr it ica l solvent is ach ieved.
EC withstands pressures up to 50 MPa at temperatures
up to 400 K. The cell cap is sea led in the bot tom par t
using a silicone O r ing. The two par t s (cap and bot tom)
are pressed aga inst each other with a fast -connect ing
mechanica l device. The pressure of the supercr it ica l
phase is monitored upst ream and released downst ream
through the BPR (Tescom, model 26-1722), which can
be either heated or not so that it can be at tempera tures
h igher or lower than the ext ract ion tempera ture. After
homemade modifica t ions, the BPR allows cont rol of the
in line pressures to with in 0.5%. It can be used up to
473 K and 70 MPa. At the out let of the BPR, the
pressure is reduced to about a tmospher ic pressure, and
then a recover ing liqu id solvent (a sufficien t ly good
solvent a t a tmospher ic pressure to recover a ll of the
solu te) st ream is used to get the solu te in liqu id sta te
for collect ion . Without th is solvent , the solu te would
prec pita te dur ing he pressure drop, and th is would
lead to potent ia l clogging. Fina lly, a separa tor S is used
to vent the gas and collect the solvent phase. At the end
of each exper imenta l run , the liqu id solvent line is
wash d with fresh solvent to recover a ll of the solu te.
The tota l volume of gaseous CO2 (ext ract ion solvent ),
V1, is measured by means of a volumeter GV, and the
concent ra t ion of solid in the solu te recover ing liqu id
phase C2L is measured by gas or liqu id chromatogra-phy. With these two data and the tota l volume of the
solu te recover ing liqu id solvent , VL, determined, the
solubility, y2, of the solid in supercr it ica l flu id is
ca lcu la ted by
where
and
n is the mole number , F the density, and M the
molecula r weight . The solubility uncer ta in ty depends
st rongly on the exper iment dura t ion : the longer the
t ime, the more accura te the quant it ies used in the
ca lcu la t ion of the solubility. As a consequence, the
Figure 1. Flow diagram of the appara tus.
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Figure 8. Experimental device for solid solubility measurements in SCF 
  
III. PARTICLE GENERATION: LIMITATIONS OF TRADITIONAL 
PROCESSES AND INTERESTS IN USING SFC-BASED 
TECHNOLOGIES 
 
 
 
The use of materials as finely divided powder is ubiquitous in industry. Whatever the domain 
involved: mineral industry, fine chemistry, cosmetics, agro-food industry, paints, 
pharmaceuticals, detergents, ... powders are largely used. 
 
Generation of fine particles can be achieved by two main routes:  
 
• size reduction: crushing, grinding, milling, comminution, micronisation 
• crystallisation: precipitation, atomisation, crystallisation by evaporation, cooling  or variation 
in ionic strength 
 
 
III.1. Size reduction 
 
Because of their relative simplicity the processes using the first route are still extremely used 
in industry.  
However, they have inherent drawbacks which may hinder or even prevent their use:  
 
• Low energetic yield 
• Pollution by the grinding medium 
• Limited control on particle size (generation of undesired dust) 
• No control on particle shape 
• Broad particle size distribution 
• Not usable with thermolabile products or hazardous chemicals 
• A low limit in mean particle size of a few micrometers beyond which it is extremely 
difficult to go 
• In some specific applications there is the need of the use of an adjuvant 
• At least one step of sieving is compulsory to complete the process 
 
III.2. Crystallisation 
 
The second route uses the generation of a solid phase from a fluid phase. The most classical 
processes using this route are:  
 
  
• Spray-drying, atomisation: the liquid medium (very often water) is evaporated by exposure 
for a short time at high temperature yielding a solid residue previously solubilised in the 
medium 
• Precipitation: a chemical reaction involving  two (or more) reactants leads to the formation of 
a solid phase insoluble in the liquid 
• Crystallisation: by tuning either the temperature, the pH, the ionic strength or by evaporating 
the solvent, nuclei of solid particles are formed and grow, finally leading  to a powder. 
 
As in the first route this second type of processes share several disadvantages:  
• no control of crystal polymorphism 
• residual solvent 
• need for an additional drying step 
 
All these processes are performed at atmospheric pressure, which is very seldom used as a 
variable. 
 
III.3. Supercritical fluid technology 
 
Supercritical fluid technology appears to be a third route for particle generation [44, 45]. Most 
of the drawbacks of the two previous routes are avoided and in addition some products cannot be 
micronized by the classical methods. Supercritical processes give micro or even nanoparticles 
with narrow size distribution and can also be used to manufacture microencapsulation or surface 
coating of an active substance particle with a polymer. 
 
One of the main feature of supercritical fluid technology is the use of pressure as a very useful 
and practical operating parameter. Their use as a medium from which a solid phase can be 
obtained has been known for a long time [14]. However its only very recently (about twenty 
years ago) that scientific reports were published in which those properties were developed for 
particle generation. 
 
  
IV. THE RESS PROCESS 
 
IV.1. Principle of the process 
 
 
 
Figure 9. The RESS process: schematic flow diagram  
 
RESS stands for Rapid Expansion of Supercritical Solutions and is sometimes called spray 
crystallisation [46].  
 
Its principle is very simple:  
As shown in the introduction section a SCF may exhibit good solvent capacity for solid 
compounds. Moreover, this solvent power is dependent on the fluid density, which can be varied 
by modifying temperature and pressure ("a SCF is dense and compressible" in other words it can 
be a good or a poor solvent depending on the operating conditions). 
 
Therefore a solid dissolved in a SCF can be crystallised from the homogeneous supercritical 
solution -P and T are chosen to give a monophase mixture- provided the density is low enough. 
The easiest way to provoke a drop in density is to force the fluid to pass through a hole or a 
capillary or a nozzle in which an adiabatic expansion can be achieved. Nozzle diameter must be 
small enough to allow a large depressurisation. Typically it is of a few decades of micrometers. 
Downstream from the nozzle, the fluid is generally in the gaseous state with a very poor solvating 
power. Figure 9 gives a schematic view of a device for RESS particle production. 
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IV.2. Optimisation of the RESS process 
 
First of all, it is necessary to have the best possible understanding of what happens upstream 
from the nozzle that is to say during the extraction step. Therefore, it is important either to collect 
data from the literature when they exist, or to perform experiments or modelling, about the solute 
solubility in the SCF. Chapter 2 gives a brief overview of the measurement and the modelling of 
the solubility of a solid in a SCF.  
The key parameters of this extraction step are obviously the operating T and P. The flow rate 
of the fluid may also play an important role since a thermodynamic equilibrium may or may not 
be reached in the extraction autoclave. In fact, the kinetics of the dissolution must not be 
neglected and diffusional limitations can occur. Additional problems may be encountered when 
the solid to be extracted is not a pure component. Fractionation of the load can lead to a variation 
in the composition of the particles upon depressurisation. 
 
Figure 10. RESS expansion in the pressure-enthalpy diagram for pure CO2 
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To understand what will happen during fluid expansion, a Mollier diagram (pressure P vs. 
molar enthalpy h) is very useful [47]. An acceptable assumption is to consider that the 
depressurisation is an iso-enthalpic process (in fact there is a variation of kinetic energy of the 
fluid, which should be taken into account). Therefore, the expansion step will be a vertical line on 
this diagram. 
Such a drop in pressure implies an important decrease in temperature as shown on figure 10 
which is the Mollier diagram for pure CO2.  
 
In the example shown on this figure, the starting point as well as the arrival point, are chosen 
to be in the single-phase zone of the diagram. However, to ensure such conditions, the 
temperature before expansion must be rather high which may be incompatible with the solute to 
be extracted. A lower pre-expansion temperature may lead to a condensation or freezing of the 
SCF (the triple point of CO2 is at 5.2 bars). 
 
Some authors have pointed out the fact that to compensate this drop in temperature, the nozzle 
can be heated  [48]. The potential problems are clogging due to the solute crystallisation and the 
possible appearance of a liquid and/or a solid phase of the solvent.  
In order to avoid these problems, several possibilities exist: a proper geometry of the nozzle 
(length, diameter, ratio of one to the other,...) can prevent any plugging, while an adequate choice 
of the values of T and P (as shown on the diagram) may allow only a single fluid phase and a 
solid phase. In particular, the pre-expansion temperature as already noted but also the post-
expansion pressure are of the utmost importance. 
Nevertheless, this latter solution is not always practicable, particularly with thermosensitive 
molecules. In such cases a heated nozzle or a heating device just upstream from the nozzle can be 
very useful. To determine the thermodynamic route of the depressurisation, it is necessary to 
calculate the heat transfer from the nozzle to the fluid. 
 
Nucleation of the solute occurs during the sudden expansion of the solution and is due to the 
mechanical perturbation, which propagates at the speed of sound leading to very uniform 
conditions [49] and therefore to a very narrow particle size distribution. 
 Indeed, the expansion time depends not only on the speed of sound (which varies with the 
operating conditions and the nature of the fluid) but also on the length of the capillary nozzle. 
However, an approximation between 10-4 to 10-6 second has been proposed [50].   
It is during this very short period of time that solubility falls by several orders of magnitude 
leading to large supersaturation ratios. This ratio is defined as the concentration of the solute over 
the solubility (the concentration at saturation).  
 
  
 
Eq. (21) 
 
 
 
 
S =  cc *
  
The driving force of the nucleation process is the difference between the chemical potential of the 
solid in both phases (fluid and solid) which is related to the activity of the solute in the solution 
and at equilibrium [51]. A simpler way to express this is to say that the supersaturation drives the 
nucleation. 
This supersaturation comes from the drop in density which is very large especially near the 
critical point. The value of the enhancement factor (see & 2.1) which can be as high as 105 or 106, 
can give an idea of the large supersaturation ratios obtained, provided the fluid after expansion 
can be considered to be an ideal gas. This is the case when the expansion pressure is close to 
atmospheric pressure. 
 
However, the expansion, may not be complete and can be controlled. It may be advantageous 
to limit the depressurisation and to let a pressure of a few tens of bars. This will diminish the 
supersaturation ratio but the recycling of the fluid might be facilitated. In fact relatively small 
changes in pressure may cause a dramatic fall in density and therefore in solubility. Again, the 
h,P diagram shown in figure 10 is of great help to determine which conditions can be used.  
 
The most obvious drawback of RESS is the lack of solubility of several families of molecules 
in the CO2. To overcome this problem one way is to change the supercritical fluid. However, this 
is seldom possible since the few other candidate molecules (N2O, light hydrocarbons,...) are 
much more hazardous than is CO2 [52]. 
Another possibility is to use the RESS process with a co-solvent [53] being previously 
dissolved in the CO2. In this case the advantage of not using any chemical solvent is lost but it 
might be interesting to use a co-solvent using such low-toxicity solvents like acetone or ethanol.  
 
The phase diagrams (h, P or P, T) of the binary mixture is different from the pure component 
diagram. As an example, the P, T diagram for the mixture (95 % CO2 - 5% Ethanol) shows that 
the two-phase envelope is considerably enlarged by the addition of 5 % co-solvent (figure 11). 
This has to be taken into account when determining the operating conditions.  
 
Chang and Randolph [54] showed that addition of up to 1.5 % mole fraction of toluene in 
supercritical ethylene enhances b-carotene solubility while particles obtained trough expansion 
remained unchanged. The maximum mole fraction was determined to maintain a single phase 
fluid after depressurisation. 
The choice of the proper co-solvent is not trivial and the affinity two-by-two supercritical 
fluid, co-solvent and solute are to be considered. A mixture of co-solvents may also be used [55]. 
Moreover, it is not possible to predict the co-solvent effect from the solubility of the solute in 
the liquid co-solvent. Therefore, solubility measurements of the solid in the mixture SCF-co-
solvent are highly recommended [44, 56].  
 
 
 
 
 
 
 
  
Mole fractions: CO2=95% and Ethanol=5% (Calculation: PR EOS) 
Figure 11. P,T diagram of a CO2-Ethanol mixture 
 
 
 
IV.3. Particle size and morphology: towards a modelling of the process 
 
The particles obtained by this route are expected to be small with a narrow particle size 
distribution (PSD).  
The rate of nucleation as well as the size of nuclei is inversely proportional to the square of Ln 
S. Very high values of S will therefore give very large number of small nuclei.  
 
One possible way to control particle size is therefore to adapt the supersaturation by varying 
the drop in pressure through the nozzle. Alessi et al. [57] have shown that an increase in the 
pressure of the expansion vessel or a decrease in the pressure upstream the nozzle led to an 
increase of the particle size. In addition, the growth of the crystals occur in the jet [58] and the 
  
mean particle size is much larger (most articles claim particles ranging from several hundreds of 
nm to a few µm) than those predicted by the theory. Debenedetti [59] gave a critical nucleus size 
of 20 nm for phenanthrene in SC-CO2. Nevertheless, submicronic particles can be obtained [60]. 
 
By modelling the evolution of pressure, temperature and density along a capillary nozzle, 
Debenedetti et al. [61] have evidenced the role of density in a capillary nozzle on particle size 
and morphology. Ksibi et al. [62] made a numerical simulation of the RESS process in which 
solute nucleation is taken into account in addition to the jet hydrodynamics influenced by the 
nozzle geometry. 
 
Working with polymers in CHF2Cl, Lele & Shine [63] also found that the morphology 
changes with the fluid density at the nozzle entrance. The same authors [64] could correlate the 
morphology obtained, fine particles or fibres, with the time-scale available for phase separation. 
It is noticeable that for polymers the precipitation occurs from a polymer liquid rich phase after a 
liquid-liquid phase separation. Large fibres were obtained when phase separation had occurred 
early, upstream the nozzle, while fine (0.2 to 0.6 µm) particles were produced for a late, in the 
nozzle, phase separation.  
 
More recently, Helfgen et al. [65] developed a numerical model to predict particle formation. 
Using CO2 and CHF3 as solvents they made particles of cholesterol, griseofulvin and benzoic 
acid. They showed that the nucleation occurred in the supersonic free jet and that particle growth 
was mainly due to coagulation. 
 
 
IV.4. Applications of the RESS 
 
There are numerous published examples of particles produced by RESS.  
 
There are some reports with inorganic compounds, mainly not with CO2 (such compounds 
exhibit too low a solubility in CO2) but other solvents like pentane or water. In the domain of 
ceramics processing, Matson et al. [66, 67] worked on ceramics and produced powders and fibres 
from silica and polycarbosilane. To intimately blend different ceramic materials a possible 
process is to dissolve them in supercritical water and to expand the solution to form ultrafine 
powders. These powders are then sintered and this next operation can be greatly facilitated by 
finely divided and ultra-pure powders. 
 
Among the papers reported with other supercritical solvents, Sun et al. [68] made nanoscale 
lead sulphide (PbS is a semiconductor) using a RESS process modified in two ways. The 
expansion was done in a liquid solution and a reaction occurred, one reactant being dissolved in 
the SCF and the other in the liquid receiving solution. The solvents used were ammonia, 
methanol and acetone. 
 
 
  
It is however the domain of organic molecules which have been the most extensively studied.  
 
 
There are a few examples of applications in the agro-food industry:  
 
• Cocoa butter which crystals present several polymorphs [69] is a good candidate to be treated 
by RESS [70] 
• b-carotene, a vitamin precursor which presents a rather good solubility in supercritical CO2 
[71, 72], nitrous oxide [4] and ethane [73], will probably deserve to be studied in the goal to 
produce particles [54].  
 
However, most of the foodstuffs are not expensive enough to allow a crystallisation by means of 
supercritical technology. 
 
Due to their high added value, it is the pharmaceuticals, which are by far the most studied. The 
use of RESS for producing drug controlled release systems  (with a polymer) has also been 
widely studied. 
Several reviews have already listed most of these works [48, 49, 74]. Among the 
pharmaceuticals one can cite (from supercritical CO2 instead otherwise specified):  
 
• lovastatin, a hypocholesterol drug [75, 76],  
• b-estradiol, a steroid [15], 
• salicylic acid, an antalgic [77], 
• caffeine, theophylline [78],  
• cholesterol [65, 79], 
• phenacetin, an analgesic [80],   
• hormones: progesterone, testosterone [48],  
• ibuprofene, an anti-inflammatory drug [81], 
• stigmasterol [82],  
• griseofulvin, an antifungal drug, obtained from supercritical CHF3 [83], 
• carmabazepine, an anticonvulsant [84], 
 
However it is clear that a lot of work done in the research laboratories of pharmaceutical 
companies have never been published. 
 
Knutson et al. [74] reviewed the use of the RESS process for producing polymeric 
microspheres containing active substances. These devices are aimed for controlled drug delivery 
and are very often made of an active drug coated by or encapsulated in a biocompatible polymer. 
The most used polymers are the poly-lactic acids (PLA) and poly-glycolic acids (PGA) which are 
known for their good compatibility with the human body. 
 
 
 
  
The drug and the polymer must be dissolved in the fluid (generally CO2). They can be 
dissolved in the same vessel or independently and both streams are joined before entering the 
nozzle. Because of the poor CO2 solubility of most polymers, co-solvents such as 
fluorohalocarbons have been used [85]. However, their toxicity as well as their negative impact 
on the environment reduce the interest for such a process.  
Lovastatin, has been crystallised as needles embedded in microspheres of DL-PLA [74]. 
 
IV.5. Conclusion and perspectives for RESS 
 
RESS remains interesting because of its simplicity of use. It has proven to be usable with all 
kind of molecules and particularly with active pharmaceutical drugs. It can also be used with 
polymers to give encapsulated particles for control drug delivery. 
 
The conditions gathered in a RESS process exhibit several advantages due to the huge 
supersaturation ratios and the fact that the solvent after expansion returns to a gaseous state:  
 
• Particles are very fine 
• Particles are monodisperse 
• The fluid can be recycled 
• There is no contamination or residual solvent  
• Thermolabile molecules can be processed 
• Chemical or shock sensitive molecules can be processed 
• Control of polymorphism is sometimes possible[84]. 
 
In spite of a very large numbers of publications on this process, most authors agree that RESS 
is very often limited by the solubility of the solute to be crystallised. This explains why processes 
using a supercritical fluid as an anti-solvent have been so widely developed in recent years (see 
chapter 5). In addition, a lot of work on modelling the nucleation and growth of the crystals in the 
jet remains to be done. Most of the reports show that particle size and morphology are generally 
not well controlled and each particular case needs a specific study. The influence of nozzle 
geometry probably deserves much more work. 
However, when facing the problem of getting a very fine crystalline powder, RESS remains 
the first process to test. A low solubility can in some instances be accepted or overcome. 
Appropriate tuning of the fluid density and the use of an adequate co-solvent are two powerful 
tools which use may completely change the fate of the industrial use of RESS for a specific 
molecule. 
 
An additional advantage, on an industrial point of view, lies in the fact that the principle of 
RESS have been described for more than one century ago. That means that no patent can be filed 
on the particle generation itself. 
 
   
 
V. THE SAS PROCESS AND RELATED TECHNOLOGIES 
 
V.1. Principle of the process 
 
Figure 12. The SAS process: schematic flow diagram 
 
 
When the solute is not soluble enough in a supercritical fluid, this can be used as an anti-
solvent. 
This type of process is particularly recommended with molecules such as sugars, proteins, 
polymers, metallic oxides and polymers that are known for their very poor solubility in SC CO2. 
The general acronym for this family of processes is SAS for Supercritical Anti Solvent. The 
rationale of the process is as follows:  
In addition to the substance to be produced as a powder and the SCF, a third component, very 
often an organic solvent has to be used. This solvent is chosen for being a good solvent of the 
component to be micronised and ideally, it should meet three different requirements:  
 
- it must solubilise the solute in relatively large amounts 
- it must have good compatibility with the anti-solvent. It is even better if it is completely 
miscible. 
- it will not persist in the crystallised solute after process is completed. 
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When both the organic solution and the anti-solvent are contacted, the antisolvent dissolves in 
the organic phase decreasing the density, the solvent power and therefore the solubility of the 
solute. At the same time the solvent evaporates in the supercritical phase increasing the solute 
concentration. It is this mass transfer in both directions which accounts for the rapid 
supersaturation of the solute and therefore the nucleation of crystals. 
 
Several ways of achieving a SAS process can be encountered:  
 
• Figure 12 gives a schematic view of a SAS device in which both streams are contacted at the 
nozzle. This operating method has been referred to as the SEDS process, for Solution 
Enhanced Dispersion by Supercritical Fluids [86]. It is a continuous process except for the 
particle collection which has to be done batchwise. The solvent can be collected in separators 
while the antisolvent can be recycled by compression, heating and re-injection. Washing of 
the expansion vessel with pure SCF is recommended before particle collection. Ruchatz et al. 
[87], have demonstrated the importance of process parameters on the solvent residues 
concentration. 
 
Several other possibilities exist:   
 
• For instance the SCF can be injected in the solution in a closed vessel (batch mode) which is 
known as GAS process for Gaseous Anti Solvent. In this case the rate of addition of the SCF 
is obviously an important parameter. The SCF provokes an expansion of the solution which in 
turn gives supersaturation and particle formation. The vessel has to be returned to 
atmospheric pressure to collect the particles The solvent must therefore be eliminated by flow 
supercritical fluid throughout the vessel in order to "dry" the particles. An appearance of a 
liquid phase rich in organic solvent must be avoided in order not to solubilise the solute again. 
This batch mode has several drawbacks: the pressure increases continuously during operation 
meaning that the supersaturation is not controlled, which leads to wide particle distribution. 
Moreover, it is not really suited to industrial applications. 
• The organic solution can be sprayed in a vessel in which supercritical fluid is flowing. The 
dissolution of the SCF in the solution droplets provokes the particle generation, which can be 
collected afterwards in the vessel while the mixture SCF-solvent can be sent to a separator. 
This process is called ASES  (for Aerosol Extraction Solvent System). 
• Such a process in batch mode, where the solution is introduced into a closed vessel containing 
the dense compressed anti-solvent [88] has been given the name PCA (for Precipitation with 
Compressed Antisolvent). 
 
 
 
 
 
   
V.2. Optimisation of the SAS process 
 
 
Several parameters have an influence on the size and the morphology of the obtained particles. 
As with the RESS process the operating T and P upstream and downstream from the nozzle are 
obviously key-parameters. The role of the nozzle is to favour droplet formation which is rather 
different from the RESS case in which the main role of the nozzle is to provoke a huge drop in 
pressure. Nozzle geometry is also an important parameter in controlling the process. In addition, 
the concentration of the solute in the solution and the relative flow rates of the solution and the 
anti-solvent are also to be taken into account. 
 
The volumetric expansion of the organic solvent due to the dissolution of the anti-solvent has 
been recognised as an important parameter [89, 90]. Most of the former papers described SAS in 
batch mode and therefore the main phenomenon was the volumetric expansion of the organic 
solution upon injection of a compressed SCF.  
 
This expansion is defined by the following equation:  
 
 
 Eq. (22) 
 
V is the volume of the liquid expanded phase while V0 is the volume of the pure solvent 
before the anti-solvent injection. 
 
Using a view cell it has been possible to directly measure the volumetric expansion. As an 
example, figure 13 shows the volumetric expansion of a classical organic solvent, DMSO, in 
CO2. The volume of the liquid phase increases with pressure. However, for a given pressure the 
volume expansion is less pronounced as the temperature increases. Warwick et al. [91] showed 
such an expansion with another solvent, DMF, versus the mole fraction of CO2. It was noticed 
that all the isotherms overlap in a single curve which have the same shape of those presented in 
figure 13. Therefore, the volume expansion for a given solvent depends only on the mole fraction 
of both constituents. 
 
The volume expansion can be predicted by using an equation of state with quadratic mixing 
rules (see & 2.2). Reverchon [92] reviewed the studies in which several authors have measured 
this expansion depending on the operating conditions and on the nature of the solvent. These 
observations are of the utmost importance for the batch mode processes where the particle are 
produced from a liquid phase rich in solvent. 
 
 
ΔV = V (P, T) -  V0V0
   
De la Fuente et al. [93] defined the volumic expansion from the molar volumes and they 
showed on the mixtures CO2-toluene-phenanthrene and CO2-toluene-naphtalene that the 
minimum of volumic expansion corresponds to the solid crystallisation. 
 
Figure 13 (from Reverchon, [92]). Volumetric expansion of DMSO in CO2 
 
 
From an industrial point of view, it is the semi-continuous mode where there is a co-injection 
of the supercritical anti-solvent and the liquid solution which appears to be the most promising. 
 
The expansion curves are therefore less pertinent since the phenomena involved are rather 
different. The particles are formed from the drops of the solution which collide into the fluid 
phase. As the antisolvent flow rate is generally much higher than those of the solution, one can 
use the P,h diagram to see how many phases are present at the equilibrium.  
 
An example has been given in figure 11 with the diagram of a 95 % CO2-5% Ethanol mixture. 
This may correspond to a practical ratio of the anti-solvent over the solution of about 20. This 
diagram shows the two-phase envelope which is to be avoided in order not to have a liquid phase 
in the expansion chamber. Such a liquid phase might re-solubilise the particles formed. 
 
V.3. Particle formation mechanisms 
 
In semi-continuous processes which are those most studied today because of their potential 
industrial applications, the mass-transfer and nucleation occur at the surface of solution droplets 
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in a continuous flow of antisolvent. It is therefore necessary to understand the fate of these 
droplets. There is a competition between two phenomena which occur simultaneously:  
 
• the anti-solvent effect i.e. the dissolution of the anti-solvent into the solution. The 
consequence is the swelling of the solution droplets. 
• the evaporation of the solvent into the anti-solvent. The consequence is the shrinking of the 
solution droplets. 
 
A key-question must therefore be addressed:  
Do the droplets of solvent in a flow of antisolvent swell or shrink? 
 
Shekunov et al. [94] showed results obtained with optical methods, image analysis, laser 
interferometry and PIV. They showed that droplets of ethanol in a turbulent flow of supercritical 
CO2 do not swell as expected but on the contrary seem to retract as long as the ethanol dissolves 
("evaporates") in the CO2. Depending on the pressure (below or above the critical mixture point) 
the behaviour of the droplet changes:  
At low pressures (below the mixture critical pressure) the droplets of ethanol decrease 
regularly. Nucleation and growth of crystals occur at the droplet interface leading to 
agglomerated particles.  
At higher pressures, a liquid ethanol jet appears from each droplet. Nucleation occurs within 
the shrinking ethanol-rich droplets and the mixing regime has a great importance. No swelling 
has been observed whatever the operating conditions.  
Reverchon [92] observed that the particle morphology is linked with the expansion volume 
DV. Interpretating the results from different series of batchwise experiments, this author assumed 
an expansion of liquid droplets in all cases. 
Low DV led to agglomerated particles.  Obtained in batch mode, these particles were obtained 
from a crystallisation in the liquid phase.  
Intermediate values for DV gave particles in the shape of hollow spheres called "balloons". 
The proposed mechanism is a fast expansion of the droplets. 
 Finally, at the highest values for DV, the smallest particles with a narrow particle size 
distribution were obtained. Balloon disintegration was proposed for the involved mechanism. 
However, a crystallisation from fast-shrinking droplets cannot be excluded. 
In addition, some growth phenomena such as coalescence can also greatly modify the 
morphology of the final powder.  
 
 
V.4. Modelling the SAS process 
 
 
Phase equilibria calculations are at the basis of tentative for modelling SAS. However, when 
using a semi-continuous process, the data from fluid phase equilibria analysis are not sufficient. 
Fluid dynamics and crystallisation must also be taken into account. Crystallisation is by 
definition a non-equilibrium phenomenon and when high supersaturation ratio are suddenly 
   
achieved as it is the case is these processes the particle generation cannot be described -or 
predicted- only from thermodynamics. Kinetic aspects are also important as well as 
hydrodynamics in the jet, mass transfer and nucleation kinetics which have also to be taken into 
account. Ideally a model must address these three domains:  
 
• thermodynamics: a good knowledge of the binary solvent-antisolvent system 
is needed. Operating T and P can be chosen from these data. The dissolution 
of the antisolvent in the solvent or on the contrary the "evaporation" effect of 
the solvent in the antisolvent can be favoured by these means. 
• hydrodynamics: the geometry of the jet at nozzle exit and the way it breaks 
up (linked with its velocity and its turbulence) determines the droplet 
production. In addition the surface tension and the viscosity of the solvent 
play a role. 
• crystallisation: mass transfer in both directions (solvent towards antisolvent 
and vice-versa) has to be simulated to know how supersaturation ratio are 
reached. 
 
Lora et al. [95] have recently given a simulation of a semi-continuous SAS with CO2 as 
antisolvent, toluene as the solvent and naphtalene and phenanthrene as solutes. 
 
They showed that the three-above cited issues must be addressed: phase equilibria, 
hydrodynamics and mass transfer. Using some simplifying assumptions, they gave an interesting 
simulation of the SAS process provided the phase equilibria of the binary system solvent-
antisolvent is known. Their calculations showed that the solvent droplets undergo a rapid 
swelling followed by a slower shrinking phase. CO2 dissolution in the solvent and solvent 
evaporation into CO2 increase with the CO2 solubility in the solvent: toluene was compared with 
acetone and DMSO.  
 
Crystallisation of the two tested solutes varies: the anti-solvent effect is sufficient to provoke 
phenanthrene crystallisation while solvent evaporation is involved in naphtalene crystallisation. 
The variation of the flow rate ratio solvent/antisolvent is therefore important for the latter solute 
while it is ineffective on the first solute. 
 
Werling & Debenedetti [96] have also studied the CO2-toluene system (without a third 
component to be crystallised). Using numerical modelling of mutual mass transfer between CO2 
and toluene, they showed that under sub-critical conditions the droplets undergo first a swelling 
followed by a shrinking phase. The same authors [97] showed the dependence of droplet fate on 
the respective densities of the solvent and the antisolvent. When the antisolvent density is lower 
than that of the solvent - the most common case- the droplets can swell. However, they shrink in 
the opposite case. They also demonstrate that the extent of swelling (or shrinking) as well as the 
lifetime of the droplets are very sensitive to the operating conditions.  
 
 
   
To optimise the production of particles from the droplets, and particularly when very fine 
particles are expected it is advantageous to work in the single-phase zone at high pressures where 
higher mass transfer and higher supersaturation ratios can be obtained. In this zone, the average 
lifetime of a droplet is short, implying rapid mass transfer, high supersaturation ratios and finally 
very small particles. They conclude that designing a semi-continuous SAS process must take into 
account the solvent-antisolvent phase behaviour in order to avoid the region close to the critical 
mixture point. 
 
More recently, the Bradford group [98] studied the effect of mixing on paracetamol 
crystallization from an ethanol solution in SC-CO2. A high Reynolds number (Re> 104) in the 
nozzle ensure good micromixing and therefore small particle diameter. The reason is that, in the 
jet, the nucleation process competes with mixing. Both experimental and computational data 
were given. Particle size exhibits a rapid decrease when Re rises up to 104, reaches a minimum 
and then undergoes a slight increase attributed to a decrease of residence time in the zone of high 
supersaturation. Particle size was also found to be dependent on nozzle diameter. The authors 
conclude that additional work is needed on nozzle geometry and size and on crystallisation 
kinetics before proposing a more complete model, able to give accurate prediction of particle size 
distribution. 
 
V.5. Control of crystal polymorphism  
 
An important issue in crystallisation can be the crystal polymorphism. A substance may exist 
in different forms at solid state. Depending on how the molecules fit together, different 
polymorphs can be encountered. This can be important in the quality of a given product. It is well 
known for instance that some less stable polymorphic forms of cocoa butter in chocolate are 
responsible for the white powdery surface called fat bloom. In the pharmaceutical field an active 
substance may exhibit different activities depending on the polymorph. The classical 
crystallisation techniques usually lead to a mixture of different polymorphs because of the multi-
step process used. It is therefore interesting to check if the supercritical crystallisation (a single-
step unit) may give different results. 
 
Kordikowski et al. [99], worked with sulfathiazole a compound having five different 
polymorphs. Using a semi-continuous SAS process with methanol and CO2 they showed that a 
good choice of the flow rate of methanol and the operating temperature may lead to a pure 
polymorph. Three pure polymorphs I, III and IV could be obtained by choosing the right 
temperature. For a given temperature, the flow rate ratio methanol/CO2 has less influence as 
shown on figure 14 . However, the flow rate of ethanol allowed the particle size be controlled. 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Sulfathiazole polymorphs as a function of T and solvent mole fraction (from 
Kordikowski et al. [99]). 
 
 
With a new pharmaceutical compound Lochard et al. (unpublished data) confirmed in our 
laboratory that a pure polyphorm can be obtained by SAS while conventional crystallisation 
techniques did not allow such a result with this substance. 
 
Indimethacin, a non steroidal antiinflammatory drug has been synthesised and micronised 
using DMF as solvent [91]. Two crystal morphologies have been obtained depending on the rate 
of expansion. Slow expansion led to rhombic crystals while a mixture of rhombic and 
bipyramidal crystals resulted of fast expansion. In addition, the particles were smaller with 
increasing expansion rate. 
 
 
V.6. Applications of the process 
 
The industrial domains in which supercritical anti-solvent techniques are potentially usable are 
numerous.  
 
Explosives were among the first studied since obviously they can not be comminuted and are 
therefore good candidates for these techniques. In such cases the aim is to obtain high bulk 
density. Microparticles without voids obtained by SAS meet this requirement. Gallagher et al. 
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[100] proposed to process several explosives like RDX, HMX and nitroguanidine. They obtained 
different particle morphology depending on the antisolvent addition rate.  
 
Inorganic products, like superconductors or catalysts have also been subject to a lot of work. 
The team of Reverchon in Italy published several papers in which they report production of 
various superconductor precursors as well as catalysts precursors [92]. 
 
Natural products like lecithin from soy oil and coriander seed triglycerides  have been 
successfully fractionated by a SAS technique with hexane as solvent [101]. Soy lecithin 
precipitation from ethyl alcohol solution has also been described [102], while egg-yolk lecithin 
has been crystallised by Weber et al. [103] using hexane and ethanol. 
 
The pharmaceutical industry produces high value products of which a high percentage exhibit 
very poor water solubility, which is a major drawback for their bioavailability. These are 
probably the two main reasons explaining why supercritical techniques have been extensively 
tested with pharmaceuticals in the last ten years. The SAS family of techniques allows the 
processing of all kinds of molecules since an appropriate solvent can almost always be found.  
 
A special emphasis has been made on protein processing. With the development of new 
medicines obtained by biotechnology, more and more drugs based on active proteins are expected 
to be developed. However, the dry formulation of such molecules is difficult since bioactivity 
must be kept unchanged. SAS-based processes offer several advantages over classical spray-
drying (major drawback: high temperatures) or lyophilisation (cost) processes.  
 
The Princeton group published work on several enzymes: insulin, catalase, peroxydase [104]. 
Several different crystal morphologies were reported. Bioactive insulin in the form of spherical 
particles was obtained from DMSO and DMF solutions. Using RAMAN spectroscopy, Winters et 
al. [105] showed that the process may or may not induce changes in the spatial conformation of 
the proteins (insulin, trypsin and lsozyme have been tested). Insulin is that most subject to such 
changes but without any effect on the biological activity. 
 
 In another study, trypsin and lysozyme have been processed [106, 107]. Reduced mean 
particle size (0.8 µm for lysozyme and 1.5 µm for trypsin) and narrower distribution were 
observed. While almost complete biological activity has been maintained for lysozyme, only 36 
% of the trypsin activity could be recovered. Authors suspected changes in the three-dimensional 
structure of this latter protein.   
 
Antibiotics is also a class of molecules which have been subject to micronisation studies. 
Reverchon et al. [108] processed tetracyclin and amoxycillin using N-methyl 2-pyrollidone while 
ampicillin could not be micronised. With DMSO none of the three-above molecules could be 
processed. 
 
 
 
   
Several other class of drugs have also been successfully processed by the SAS technique: p-
hydroxybenzoïc acid [109], salmeterol xinafoate a drug active on asthma [86], and many others. 
Jung & Perrut [48] have given a very complete table with all the compounds which have been 
micronised with the SAS-GAS-ASES-SEDS-PCA process family. 
In addition, it is noticeable than carriers which are the main components of a pharmaceutical 
tablet have also undergone such process. Disaccharides like maltose, lactose or sucrose are 
almost insoluble in most organic solvents but exhibit a great solubility in water. Unfortunately, 
water is very sparingly soluble in supercritical carbon dioxide. This problem has been overcome 
by Palakodaty et al. [110, 111] who designed a tri-axial nozzle. This device allows a co-injection 
of three different fluids: the supercritical antisolvent, the aqueous solution of a sugar and an 
organic solution of an active substance. Water can be extracted with the organic solvent provided 
there exists a good mutual solubility of these two solvents. 
 
SAS is also a technique which allows the coprecipitation of two different compounds. Several 
advantages can be obtained in terms of formulation, dissolution rate or drug release systems. 
Hereafter are a few published examples of coprecipitation:  
 
• Carmabazepin, a drug used for the treatment of epilepsy and manic-depressive psychosis has 
been coprecipitated with PEG. Using ethyl acetate and acetone as solvents, Kikic et al. [112] 
obtained microparticles with an increased rate of dissolution. 
• Two similar molecules, acetaminophen (paracetamol) and its precursor p-acetoxyacetanilide 
have been coprecipitated by Shekunov et al. [113]. They found an incorporation of both 
molecules in a solid solution. The crystal structure of the drug can be varied by the rate of 
incorporation of its precursor. 
• Bertucco et al. [114] studied the co-precipitation of hyaluronic acid benzylic ester (HYAFF) 
with three active substances, a protein and two steroids. The polymer precipitated into 
amorphous submicronic spherical particles containing the drug. However they noticed an 
adverse effect due to a non-negligible solubility of two of the active substances in the 
antisolvent (CO2). 
• Sze Tu et al. [109] performed the coprecipitation of a model drug (p-hydroxybenzoic acid) 
with bioerodible polymers PLA and PLGA. The solvents used were acetone, methylene 
chloride and methanol. They obtained microparticles with a size decreasing with an 
increasing pressure for PLGA while the reverse was observed for PLA. Most of the polymer 
microspheres were less than 2 mm in size. 
 
The micronisation of polymers has also been reported. Dixon et al. [88] studied the formation 
of polystyrene microspheres. But it has been the biocompatible polymer family and especially the 
poly-lactic acid (PLA) and its copolymers with glycolic acid (PLGA) which have been the most 
studied. Bleich et al. [115] used methylene chloride as solvent and obtained micro-particles of 
PLA.  
 
 
   
V.7. Conclusion and perspectives for the SAS process 
 
SAS and related processes have been the subject of an increasing interest during the last five 
years. In the early 90's more papers were published on RESS than on SAS. This has now 
completely changed and the literature has been enriched by numerous articles on the use, the 
modelling, and the applications of SAS over the last few years. 
The first major interest of SAS is that it is usable with all kinds of molecules. A very broad 
range of materials can be processed since there is almost always a useful "solvent-antisolvent" 
couple. Once the antisolvent has been fixed (CO2 represents probably more than 95% of the 
applications), the choice of the solvent is crucial. It must be at the same time a good solvent for 
the solute of interest and exhibit some miscibility with the CO2. Usual solvents like ethanol, 
toluene, acetone, etc. show complete mutual miscibility with CO2. However, when the solvent is 
a large molecule it might be different and the quantity of CO2 able to dissolve in the solvent can 
be low. In other words the antisolvent effect might be too weak to obtain a good nucleation. 
 
The ratio of the two flows is extremely important as well as the geometry of the chamber (or 
the nozzle) where both fluids are contacted.  
 
Particle have been formed from explosives, superconductor precursors, polymers, proteins, ... 
Their morphology can vary and hollow balloons [92], spheres, fibres [116], have been described. 
 
Despite several recent work done on modelling the SAS process [96, 97], the influence of the 
process conditions on the type of particles obtained is far from being completely elucidated. 
   
 
VI. PGSS, SFC-ASSISTED MICRO-ENCAPSULATION AND OTHER 
PROCESSES  
 
VI.1. The PGSS process 
 
Figure 15. The PGSS process: schematic flow diagram 
 
 
 
PGSS stands for Particle generation from Gas Saturated Solutions. A dense gas can be 
solubilised in large quantities in a liquid. This property is used in the PGSS process. 
 
A dense gas, most often carbon dioxide, is dissolved in a first autoclave into a liquid, which can 
be either a solution (sometimes a suspension) of a compound or a melted solid. 
A gas-saturated solution is obtained which can be further expanded through a nozzle in an 
expansion chamber as shown in figure 19. Generation of solid particles (or liquid droplets) is 
induced in this second vessel, then particles can be collected after completion of the process. 
This process has been mainly used on polymers in which high amounts of carbon dioxide can 
be dissolved. In addition, properties of the polymer such as glass transition and melting 
temperatures or density can be modified. If a third component is previously dissolved or 
suspended in the polymer, the final depressurisation may lead to micro-spheres of polymer with 
an embedded substance. A difference from RESS and SAS processes another property of the CO2 
is used in the PGSS: by dissolving in a liquid at high pressures, CO2 reduces viscosity which may 
facilitate the handling of the solution. 
 
The main industrial application of such a process is known as the "Unicarb®" process 
patented (several patents, for review see [48]) by Union Carbide [117]. Supercritical carbon 
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dioxide acts as a diluent of paints, anti-adhesive coatings or varnishes. However, it is not in this 
case a "particle" generation process but rather a "droplet" generation process. The main 
advantage lies in the reduction of liquid wastes which are a major drawback in the paint industry. 
 
For particle production, Knez [118] gave an overview of the main published applications: 
among them polymers [119], different kinds of lipids and two pharmaceuticals, nifedipine and 
felodipine which have been successfully micronised with the PGSS process. 
 
Another particle generation process close to PGSS has been described by Sievers et al. [120]. 
It consists in the production of a dense fine-droplet aerosol plume followed by a drying step. The 
aim of this process is to obtain fine particles usable in a dry powder inhaler form. By contacting 
supercritical carbon dioxide with an aqueous solution of an active substance in a “low-dead 
volume tee” followed by a depressurisation through a restrictor, they produced microdroplets 
which could be further dried in a stream of warm nitrogen. This patented process has been used 
with a-lactose, the classic diluent for dry powder inhaler, albuterol sulphate and cromolyn 
sodium two drugs active against asthma. Finally, fine spherical particles in the range 0.1-3 µm 
were obtained making them suitable for inhalation. 
 
VI.2. Micro encapsulation and coating processes 
 
As already mentioned, RESS, SAS and derivatives as well as PGSS can be used for micro-
encapsulation of an active substance into a polymeric matrix. This is obviously a very important 
domain since the controlled drug release is a major stake in several industries, including 
pharmaceutics, agrochemistry, cosmetics, inks, paints, etc. 
Depending on the respective solubilities of the substance to be encapsulated and the polymer 
to be used, the choice of a particular process can be made. In most of the cases a co-precipitation 
of two (if not more) compounds must be achieved. Micro-spheres, micro-capsules and liposomes 
can thus be obtained.  
With PLA, a CO2-soluble polymer, RESS is often used as in the work of Kim et al. [121] with 
naproxen.  With less CO2-soluble polymers like PEG, RESS may still be usable provided a 
proper co-solvent can be added in the supercritical fluid. Mishima et al. [122] used this property 
to encapsulate several proteins by PEG. 
With polymers non soluble in carbon dioxide, the SAS and derived processes can be 
employed. Several examples are shown in the § 4.4. 
Several processes have been proposed for coating pre-existing micro-particles. For instance, 
Richard et al. [123] described a process in which a CO2-soluble polymer is deposited onto 
particles of paracetamol by a gentle depressurisation of the autoclave. Tsutsumi et al. [124] 
combined the fluidized-bed technology with RESS to coat catalyst particles with paraffin. 
 
 
 
   
VI.3. Particles from chemical reactions 
 
It is noticeable that it is possible to manufacture small particles as a result of  chemical 
reaction. This has been used mainly with inorganic compounds: metals, metal oxides and 
ceramics. 
Powders of titanium, aluminium and magnesium oxides have been obtained by thermal 
decomposition of a precursor in a supercritical alcoholic medium [125, 126]. The same group has 
proposed a continuous process for titanium oxide production [127]. Small particles (200 to 300 
nm) were obtained at a rate of 20 g.h-1. 
Another process involves supercritical carbon dioxide as a medium for a chemical reaction 
between water and a metal-organic precursor [128]. Using this process, titanium hydroxide and 
titanium dioxide particles could be obtained by adding water in a solution of titanium alkoxide in 
SC-CO2. Very fine particles (500 to 600 nm) with huge specific surface area (> 400 m2.g-1) were 
obtained. 
 
   
 
VII. INDUSTRIAL APPLICATIONS AND STRATEGIES 
 
The pharmaceutical industry is by far the most concerned by the development of these new 
technologies [129] although several examples can be found in most of the other previously cited 
industrial domains. 
The explanation is very simple: most of the new molecules coming out of the research 
departments of the pharmaceutical industry are almost water-insoluble. 
As water is almost the last authorised solvent for drugs and obviously the basis of any 
biological fluid, one the largest challenges the scientists have to address nowadays is: how to 
make these molecules more soluble and thus available and active for living organisms ? 
The bio-availability of pharmaceutical molecules depends on their absorption by the 
gastrointestinal tract which is governed by their dissolution rate. As a consequence, the dose at 
which they have to be employed is rather high. Every living organism is unique implying that its 
own reaction to a specific drug can change dramatically from one organism to another. With this 
great variability the risk of using too high a dose is always present. 
 
Therefore, much endeavour has recently been made in order to improve this bio-availability. Two 
routes can be followed:  
1- improving the dissolution rate by micronisation techniques leading to an increase in the 
specific surface area 
2- micro-encapsulating the active molecule in order to improve its solubility 
 
Both routes are usable with SCF technologies: 
 
The first one is to generate smaller particles (mean particle size of about 1 µm or even sub-
micronic particles) with a narrow particle size distribution leading to high specific surface area 
(typically several tens of m2/g for a non-porous solid).  
The possibility of a co-crystallisation of the active molecule and the carrier is an additional 
advantage of the SCF techniques. The use of a carrier e.g. lactose is very common. As an 
alternative, impregnation of the carrier by the drug is also studied in many pharmaceutical 
research laboratories. The transport properties and the very low viscosity of SCF make the 
impregnation a very attractive possibility. 
 
Micro-encapsulation can be achieved by using polymers. Many examples have already been 
given in this paper. In addition, molecules like cyclodextrins can also be used and are very 
promising. This family of molecules are cyclic polymers of 6, 7 or 8 glucose residues. They 
exhibit a hollow cavity cone shape. The interior of the cavity is rather hydrophobic while the 
exterior is rather hydrophilic. Provided the size of the drug is compatible with that of the 
cyclodextrin, an encapsulation may occur which can enhance the solubility greatly. 
 
 
 
 
   
Another potential domain of application is the use of dry powders for lung delivery [130]. 
 
An important problem to be addressed is that the powder thus obtained must be handled and 
processed [131]. The final density of the product (active substance + carrier + excipient) must be 
compatible with the desired solid formulation. It is well known that very fine powders are very 
difficult to handle. There is therefore a need for a formulation step to render these powders easily 
usable.  
 
Most of the pharmaceutical companies either follow very carefully this field of research or 
have their own research teams. Two pharmaceutical groups have recently purchased two small 
European companies which were pioneers in this domain: Bradford particle design (BPD, located 
in Bradford, United Kingdom) and Separex (located in Nancy, France). Inhale therapeutics 
systems bought BPD and Lavipharm laboratories took over Separex.  
 
The scaling up of these processes has been subjected to few published works. Nevertheless it 
is very likely that these studies are under way in most of the major companies not only in the 
pharmaceutical domain but also in the cosmetic industry and some agro-food companies.  
The industrial use of supercritical fluid technologies is known for requiring high capital 
investment. However the production costs are mainly the costs of energy. Moreover the 
extraction plants have demonstrated that even inexpensive products can be processed by such 
technologies. Sievers [132] has given some results of optimisation calculations for extraction 
plants. 
   
 
VIII. CONCLUSION 
 
Particle generation from supercritical fluids was born in the mid 80’s. After about fifteen years 
of infancy, this domain is now in its adolescence. Several signs of maturity begin to appear:   
 
• International conferences on SCF’s reserved a large place for particle generation consistently 
for more than five years. An increasing number of industrialists attend these meetings. 
• The understanding of the basic phenomena has progressed significantly although there is still 
a lot of knowledge to be discovered 
• Fundamental and breakthrough papers dealing with the modelling of these processes have 
recently been published 
• Interest of large companies in these technologies has shifted from sponsoring of research 
teams to the setting up of industrial plants which are expected in the coming years. 
 
However, the adulthood of this domain is far from being attained: several controversial issues 
still remain about: the influence of operating parameters on the characteristics of the particle 
produced (size, morphology, polymorphism), the comprehension of the fluid dynamics, the 
nucleation phenomenon, the crystal growth under these specific conditions, the particle 
agglomeration in the jet, the method of scaling up,  etc.  
 
It is noticeable that both RESS and SAS processes continue to undergo fundamental and 
applied research and have benefited from the recent years’ advances. Because of its simplicity, 
RESS will remain the first process to be tested while the universality of SAS will ensure future 
developments for very different type of materials.  
 
The recent advances above mentioned, as well as the inherent advantages of these 
technologies:  
• single-step process, easier downstream processing, purity of products, environmentally 
acceptable technology, possibility of manufacturing drug release systems and above all the 
unique properties of the powders obtained  
are the best insurance that this domain will continue to evolve rapidly both in research and in 
practical applications. 
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